Lynparza Phase III PAOLA-1 trial met primary endpoint as 1st-line maintenance treatment with bevacizumab for advanced ovarian cancer Read more
Janssen Announces European Commission Approval of Imbruvica (ibrutinib) for Expanded Use in Two Indications Read more
CureVac Enters into an Exclusive Collaborative Research Agreement for Discovery Research in mRNA-based Lung Therapy Candidates with Yale University Read more
Fresenius Kabi will Deliver Two Spotlight Sessions at SMi’s Pharmaceutical Manufacturing & Cleanroom Technology Conference Read more
Eidos Therapeutics Confirms Receipt of Non-Binding Proposal from BridgeBio Pharma to Acquire Shares Read more